Carolina Liquid Chemistries Launching New Blood Analyzer

April 24, 2012

“ This is chemistry analyzer is the first in its class to be designed since the 1990s,” said Phil Shugart, President of Carolina Liquid Chemistries.

Carolina Liquid Chemistries is launching the first product from its new headquarters located at the Piedmont Triad Research Park’s Wake Forest Biotech Place building.

The device, called the CLC 720, is a chemistry analyzer that can process 100 different blood chemistry tests for such things as glucose or cholesterol levels or drug abuse. The system received FDA clearance in March and is the second chemistry analyzer that Carolina Liquid Chemistries has developed in the research park.

In a press release, the company said the market for such devices is 400 instruments per year and CLC expects to obtain a 20 percent market share with its device within two years based on its advanced technology, compact size and low energy requirements.

“ This is chemistry analyzer is the first in its class to be designed since the 1990s,” said Phil Shugart, President of Carolina Liquid Chemistries.

CLC, was originally headquartered in California and had been a tenant of the Wet Lab Launchpad incubator in the research park’s Dean Biomedical Research Building, but it recently moved its headquarters into the park’s new $100 million Wake Forest Biotech Place.

“ The launch of the CLC 720 exemplifies the mission of the PTRP, which is the journey from ‘mind to market,’ said Dr. John D. McConnell, CEO of Wake Forest Baptist Medical Center , which runs the park. “Carolina Liquid Chemistries has successfully taken innovative technology from inception to commercialization, and we congratulate them on their new product launch.”